Myopia: Why study the mechanisms of myopia? Novel approaches to risk factors signalling eye growth- how could basic biology be translated into clinical insights? Where are genetic and proteomic approaches leading? How does visual function contribute to and interact with ametropia? Does eye shape matter? Why ametropia at all?

Elena Tarutta, Wei han Chua, Terri Young, Ernst Goldschmidt, Seang Mei Saw, Kathryn A. Rose, Earl Smith, Donald O. Mutti, Regan Ashby, Richard A. Stone, Christine Wildsoet, Howard C. Howland, Andy J. Fischer, William K. Stell, Andreas Reichenbach, Michael Frost, Alex Gentle, Xiaoying Zhu, Jody Summers-Rada, Veluchamy BarathiLiqin Jiang, Sally McFadden, Jeremy A. Guggenheim, Chris Hammond, Ruth Schippert, Chi Ho To, Jane Gwiazda, Susana Marcos, Michael Collins, W. Neil Charman, Pablo Artal, Juan Tabernero, David A. Atchison, David Troilo, Thomas T. Norton, Josh Wallman

    Research output: Contribution to journalArticlepeer-review

    Abstract

    On July 26-29, 2010 the 13th International Myopia Conference was held in Tübingen, Germany and included 17 separate symposia, each with 3-5 presentations. Here, in a single paper, the chairs of those Symposia describe the scientific advances noted at the conference and include the full abstracts of the individual myopia papers presented in each symposium along with the authors and their institutions. The 17 Symposia covered 7 topics: Why Study the Mechanisms of Myopia?; Novel Approaches to Risk Factors; Signalling Eye Growth- How Could Basic Biology Be Translated into Clinical Insights?; Where Are Genetic and Proteomic Approaches Leading?; How Does Visual Function Contribute to and Interact with Ametropia?; Does Eye Shape Matter?; Why Ametropia at All?
    Original languageEnglish
    JournalOptometry and Vision Science
    DOIs
    Publication statusPublished - 3 Feb 2011

    Fingerprint

    Dive into the research topics of 'Myopia: Why study the mechanisms of myopia? Novel approaches to risk factors signalling eye growth- how could basic biology be translated into clinical insights? Where are genetic and proteomic approaches leading? How does visual function contribute to and interact with ametropia? Does eye shape matter? Why ametropia at all?'. Together they form a unique fingerprint.

    Cite this